Edema and increased plasma renin activity in lithium treated patients.
D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy*; D000450:Aldosterone / Q000652:urine; D001007:Anxiety; D001714:Bipolar Disorder / Q000097:blood; D002254:Carbonates; D002746:Chlorpromazine / Q000627:therapeutic use; D004032:Diet; D004487:Edema / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012083:Renin / Q000097:blood* / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D012965:Sodium Chloride; D013148:Spironolactone / Q000627:therapeutic use
D002254:Carbonates; D013148:Spironolactone; D012965:Sodium Chloride; D000450:Aldosterone; D008094:Lithium; D012964:Sodium; D012083:Renin; D002746:Chlorpromazine